Marta Ribeiro
Overview
Explore the profile of Marta Ribeiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goncalves F, Cabanas J, Costa I, Veloso M, Ribeiro M, Fernandes S, et al.
J Virol Methods
. 2025 Feb;
334:115112.
PMID: 39923901
HIV-2 affects over 1 million people globally and can lead to AIDS if untreated. Treating people living with HIV-2 (PLHIV-2) is challenging because the virus is inherently resistant to some...
2.
Jager J, Ribeiro M, Furtado M, Carvalho T, Syrris P, Lopes L, et al.
Stem Cell Res
. 2024 Oct;
81:103582.
PMID: 39447317
Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiomyopathy and a leading cause of sudden death. Genetic testing and familial cascade screening play a pivotal role in the clinical management...
3.
Barros S, Coimbra A, Herath L, Alves N, Pinheiro M, Ribeiro M, et al.
Environ Sci Technol
. 2024 Oct;
58(44):19627-19638.
PMID: 39445516
The nonsteroidal anti-inflammatory drug naproxen (NPX) is among the most consumed pharmaceuticals worldwide, being detected in surface waters within the ng to μg/L range. Considering the limited chronic ecotoxicity data...
4.
Ribeiro M, Jager J, Furtado M, Carvalho T, Cabral J, Brito D, et al.
Hum Cell
. 2024 May;
37(4):1205-1214.
PMID: 38762696
Hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in the MYPBC3 gene, which encodes the cardiac myosin-binding protein C (cMyBP-C). Most pathogenic variants in MYPBC3 are either nonsense mutations or...
5.
Ribeiro M, Jager J, Furtado M, Carvalho T, Cabral J, Brito D, et al.
Stem Cell Res
. 2024 Feb;
76:103362.
PMID: 38417376
Familial hypertrophic cardiomyopathy (HCM) stands as a predominant heart condition, characterised by left ventricle hypertrophy in the absence of any associated loading conditions, with affected individuals having an increased risk...
6.
Ribeiro M, Martins S, Carvalho T, Furtado M, Sampaio Cabral J, Brito D, et al.
Stem Cell Res
. 2023 Dec;
74:103282.
PMID: 38104429
Familial hypertrophic cardiomyopathy (HCM) is the most common inherited heart condition. HCM patients show left ventricle hypertrophy without any associated loading conditions, being at risk for heart failure and sudden...
7.
Ribeiro M, Rebelo M, Pereira A, Antunes D, Ferreira A, Jacinto S
Endocr Metab Immune Disord Drug Targets
. 2023 Nov;
PMID: 37946348
Introduction: Dihydropteridine reductase deficiency (DHPRD) is a rare genetic disorder of tetrahydrobiopterin (BH4) regeneration, a cofactor for several enzymes, including phenylalanine hydroxylase. Due to hyperphenylalaninemia (HPA), patients can be detected...
8.
Carvalho S, Moreira L, Santos J, Gaspar P, Goncalves M, Matos L, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Nov;
PMID: 37937567
Introduction: When it comes to disease modeling, countless models are available for Lysosomal Storage Diseases (LSD). Historically, two major approaches are well-established: in vitro assessments are performed in patient fibroblasts,...
9.
Presumido P, Ribeirinho-Soares S, Montes R, Quintana J, Rodil R, Ribeiro M, et al.
Sci Total Environ
. 2023 Jun;
892:164492.
PMID: 37263431
A membrane ozone contactor, operated under continuous mode, was applied to promote the tertiary treatment of urban wastewater (UWW), targeting the removal of contaminants of emerging concern (CECs), bacterial disinfection,...
10.
Chavarria D, Borges A, Benfeito S, Sequeira L, Ribeiro M, Oliveira C, et al.
J Adv Res
. 2023 Feb;
54:251-269.
PMID: 36822390
Introduction: The infections by multidrug-resistant bacteria are a growing threat to human health, and the efficacy of the available antibiotics is gradually decreasing. As such, new antibiotic classes are urgently...